News

Keep up to date with the latest news items from GAFFI.

As the true extent of fungal diseases in Pakistan is revealed, scientists launch a new book aimed at improving the diagnosis and treatment of life threatening fungal infections which affect 3.28 million Pakistanis

December 4, 2017

How precise are country estimates of fungal disease burden? An updated analysis

October 23, 2017

Burden of fungal diseases in Turkey, Norway, Malawi and Argentina presented at TIMM, Belgrade

October 12, 2017

Already saving lives from fungal disease – GAFFI’s 4-year legacy

October 1, 2017

Professor Matthew Burton of the London School of Hygiene & Tropical Medicine appointed as a GAFFI Senior Adviser

August 18, 2017

Call for global action on life-threatening fungal infections

August 1, 2017

Major clinical trial shows flucytosine a critical component of reducing deaths from cryptococcal meningitis

July 24, 2017

Randomised trial establishes amphotericin B as best immediate therapy for Talaromyces marneffei infection in AIDS

June 29, 2017

POOR FARMER’S FUNGAL SKIN CONDITION GETS APPROVAL FROM WHO AS ‘NEGLECTED’ AFTER LOBBYING BY GAFFI

June 5, 2017

FUNGAL MENINGITIS STILL KILLING OVER 180,000 PEOPLE EACH YEAR DESPITE DRUGS AVAILABLE TO SAVE LIVES

May 8, 2017

GAFFI is the sole organization committed to enhancing the diagnosis, facilitating access to treatment, and improving outcomes in HIV-associated fungal disease.